跳至主要内容
临床试验/NCT05750771
NCT05750771已完成不适用

Comparison of Drug-coated Balloon and Drug-eluting Stent for Severe Calcification of de Novo Lesion in Elderly Coronary Heart Disease

Henan Institute of Cardiovascular Epidemiology1 个研究点 分布在 1 个国家目标入组 218 人开始时间: 2023年2月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
218
试验地点
1
主要终点
LLL

研究概览

简要总结

The goal of this clinical trial was to compare the effectiveness of drug balloons versus drug-coated stents in calcified lesions in elderly coronary artery disease. The main question it aims to answer is whether the application of DCB is non-inferior to DES for in situ large vessel calcified lesions in the elderly coronary arteries.

And to develop a method to precisely identify the nature and extent of calcified lesions and to rationalize the choice of pretreatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 1. older than 60 years of age.
  • 2. meeting the indications for coronary intervention.
  • 3. IVUS examination suggests severe calcified lesions (calcification angle > 270° at the target lesion) ;
  • 4. Target lesion vessel diameter > 2.75 mm

排除标准

  • 1. inability to provide written informed consent.
  • 2. unable to administer antiplatelet agents and anticoagulant therapy; have allergies to heparin, contrast agents, etc.
  • 3. the subject is participating in another uncompleted clinical trial
  • 4. life expectancy <1 year.
  • 5. non-in situ vascular lesions.
  • 6. cardiogenic shock.
  • 7. Patients with hemodynamic instability

研究组 & 干预措施

DES Group

Experimental

Implantation of drug-eluting stents in patients with satisfactory pretreatment

干预措施: DES (Device)

DCB Group

Experimental

Implantation of drug-coated balloons in patients with satisfactory pretreatment

干预措施: DCB (Device)

结局指标

主要结局

LLL

时间窗: 12 months

Late lumen loss (LLL) of the target lesion segment

次要结局

  • MACE(Perioperative period, 30 days, 3 months, 6 months, 12 months after discharge)

研究者

发起方
Henan Institute of Cardiovascular Epidemiology
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验